The drug development path is complex and requires the input of multiple stakeholders – from regulatory, analytical, manufacturing and supply chain. You need a partner that understands your challenges and can work with you to build an integrated plan that captures the interdependencies early on and manages them throughout the lifecycle.


What can you do to minimize risk as you transition to a combination product?